+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Inhalers Market by Product, Indication, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019 - 2026

  • ID: 4828633
  • Report
  • Region: Global
  • 185 pages
  • Allied Analytics LLP
1 of 3

The global smart inhalers market size was valued at $34 million in 2018 and is estimated to reach $1,406 million by 2026, growing at a CAGR of 58.4% from 2019 to 2026. Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose linked wirelessly to the cloud. These inhalers are part of “Internet of Things,” thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of dose, which can be recorded for understanding the patient’s daily routine.

The global smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, owing to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor that drives the growth of the smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance toward adoption of smart inhalers are expected to hinder the market growth.

The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD.

Based on distribution channel, it is divided into hospitals, retail pharmacies, and online pharmacies. In terms of geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the high CAGR, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global smart inhalers market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A quantitative analysis from 2019 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
  • In-depth analysis of the market based on products such as inhalers and nebulizers is carried out in the report.
  • The global smart inhalers market scenario is comprehensively analyzed in accordance to the key cities.

KEY MARKET SEGMENTS

By Product

  • Inhalers

o Metered Dose Inhalers
o Dry Powder Inhalers

  • Nebulizers

By Indication

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America

o U.S.
o Canada
o Mexico

  • Europe

o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

  • Asia-Pacific

o Japan
o China
o Australia
o India
o Rest of Asia-Pacific

  • LAMEA

o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT (DEVICE PROVIDERS)

  • AstraZeneca, plc.
  • GlaxoSmithKline, plc
  • Novartis International AG
  • Adherium Limited
  • Boehringer Ingelheim Group
  • Cohero Health Group
  • Vectura Group, plc.
  • Opko Health Group
  • Teva Pharmaceutical Industries Ltd.
  • ResMed Inc.
Note: Product cover images may vary from those shown
2 of 3

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top investment pockets
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping smart Inhalers market
3.2.1. Moderate bargaining power of suppliers
3.2.2. High bargaining power of buyers
3.2.3. High threat of new entrants
3.2.4. Moderate threat of substitutes
3.2.5. High intensity of rivalry
3.3. Value Chain Analysis
3.5. Industry pain point analysis
3.6. Patent Analysis
3.7. Market share analysis
3.8. Market Dynamics
3.8.1. Drivers
3.8.1.1. Increase in Air Pollution
3.8.1.2. Increase In Population Susceptible To Indoor Air Pollutants
3.8.1.3. Increasing Prevalence Of COPD and Asthma ly
3.8.2. Restraints
3.8.2.1. Misusing Data And Data Privacy
3.8.2.2. Overall High Cost Of Asthma And COPD Treatment
3.8.3. Opportunities
3.8.3.1. Increased Focus Towards Advanced Treatment Protocols

CHAPTER 4: SMART INHALERS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Inhalers
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.3.1. Dry Powder Inhalers
4.2.3.2. Metered Dose Inhalers
4.3. Nebulizers
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: SMART INHALERS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. COPD
5.3.1. Market size and Forecast
5.3.2. Market analysis, by country

CHAPTER 6: SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital pharmacies
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Retail Pharmacies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Online Pharmacies
6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: SMART INHALERS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by product type
7.2.3. North America market size and forecast, by indication
7.2.4. North America market size and forecast, by distribution channel
7.2.6. North America market size and forecast, by country
7.2.6.1. U.S. market size and forecast, by product type
7.2.6.2. U.S. market size and forecast, by indication
7.2.6.3. U.S. market size and forecast, by distribution channel
7.2.6.5. Canada market size and forecast, by product type
7.2.6.6. Canada market size and forecast, by indication
7.2.6.7. Canada market size and forecast, by distribution channel
7.2.6.8. Mexico market size and forecast, by product type
7.2.6.9. Mexico market size and forecast, by indication
7.2.6.10. Mexico market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by product type
7.3.3. Europe market size and forecast, by indication
7.3.4. Europe market size and forecast, by distribution channel
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by indication
7.3.5.3. Germany market size and forecast, by distribution channel
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by indication
7.3.5.6. France market size and forecast, by distribution channel
7.3.5.8. UK market size and forecast, by product type
7.3.5.9. UK market size and forecast, by indication
7.3.5.10. UK market size and forecast, by distribution channel
7.3.5.11. Italy market size and forecast, by product type
7.3.5.12. Italy market size and forecast, by indication
7.3.5.13. Italy market size and forecast, by distribution channel
7.3.5.14. Spain market size and forecast, by product type
7.3.5.15. Spain market size and forecast, by indication
7.3.5.16. Spain market size and forecast, by distribution channel
7.3.5.17. Rest of Europe market size and forecast, by product type
7.3.5.18. Rest of Europe market size and forecast, by indication
7.3.5.19. Rest of Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by product type
7.4.3. Asia-Pacific market size and forecast, by indication
7.4.4. Asia-Pacific market size and forecast, by distribution channel
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by indication
7.4.5.3. Japan market size and forecast, by distribution channel
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by indication
7.4.5.6. China market size and forecast, by distribution channel
7.4.5.7. India market size and forecast, by product type
7.4.5.8. India market size and forecast, by indication
7.4.5.9. India market size and forecast, by distribution channel
7.4.5.10. Australia market size and forecast, by product type
7.4.5.11. Australia market size and forecast, by indication
7.4.5.12. Australia market size and forecast, by distribution channel
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by indication
7.4.5.15. Rest of Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by product type
7.5.3. LAMEA market size and forecast, by indication
7.5.4. LAMEA market size and forecast, by distribution channel
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by indication
7.5.5.3. Brazil market size and forecast, by distribution channel
7.5.5.4. South Africa market size and forecast, by product type
7.5.5.5. South Africa market size and forecast, by indication
7.5.5.6. South Africa market size and forecast, by distribution channel
7.5.5.7. Rest of LAMEA market size and forecast, by product type
7.5.5.8. Rest of LAMEA market size and forecast, by indication
7.5.5.9. Rest of LAMEA market size and forecast, by distribution channel

CHAPTER 8: COMPANY PROFILES
8.1. Adherium Limited
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. AstraZeneca PLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Boehringer Ingelheim group
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Cohero Health, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. GlaxoSmithKline plc
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Novartis International AG
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. OPKO Health, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. ResMed Inc. (Propeller Health)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Teva Pharmaceutical Industries Limited
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Vectura Group plc
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments


*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll